Friends of Cancer Research launches Step 2 of the ctMoniTR Project

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

Two months into his job as CEO of the American Cancer Society and American Cancer Society Cancer Action Network, Shane Jacobson is still in the drinking-water-from-the-firehose stage of the job.

November 21, 2025

Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

November 21, 2025

By Mikkael A. Sekeres

Obituary

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Edward Chu was an expert in pharmacology whose research improved therapies for colorectal cancer, leading to the identification of new treatment targets and driving scientific advances in the field.

November 21, 2025

By Roy S. Herbst, Mario Sznol, Vincent T. DeVita Jr., Robert L. Ferris, Nancy E. Davidson, Otis W. Brawley, Roy A. Jensen, Weijing Sun and Montefiore Einstein staff

Obituary

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Arnold Daniel “Arnie” Kaluzny, PhD, longtime adviser to NCI and an early pioneer and contributor to what is now known as health services research, died Oct. 29 at the age of 87.

November 21, 2025

By Donna M. O’Brien and Barnett Kramer

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

November 21, 2025

By The American Society of Clinical Oncology

Cancer Policy

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Approximately one in 30 NIH-funded clinical trials—and more than 74,000 trial participants—were affected by grant funding disruptions caused by the Trump administration, according to an analysis in JAMA Internal Medicine.

November 21, 2025

By Jacquelyn Cobb

Friends of Cancer Research launches Step 2 of the ctMoniTR Project

YOU MAY BE INTERESTED IN

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

My introduction to, and lessons learned from, Rick Pazdur

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Renew today!

Subscriber content

Never miss an issue!

Login

Friends of Cancer Research launches Step 2 of the ctMoniTR Project

YOU MAY BE INTERESTED IN

Shane Jacobson talks about his to-do list for ACSBoost research, forge closer ties with cancer centers, launch an all-out campaign for resources

My introduction to, and lessons learned from, Rick Pazdur

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Never miss an issue!

Login

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources